Showing results (281-290 of 317) with videos related to
Sort By:
Pageof 32
The Lancet. Oncology|August 14, 2025
Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trialDominik Paul Modest, Marwan Fakih, Lisa Salvatore, et al.Neuro-Oncology|July 8, 2022
Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patientsJesús Reyes-González, Francisco Barajas-Olmos, Humberto García-Ortiz, et al.The New England Journal of Medicine|October 23, 2023
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12CMarwan G Fakih, Lisa Salvatore, Taito Esaki, et al.Frontiers in Medicine|January 2, 2023
Evaluation of procalcitonin elevation during ICU stay and its relationship with mortality in ICU patients for COVID-19 with respiratory involvement. A multicenter prospective cohort studyRicardo Rivera-Fernandez, Luis Yáguez-Mateos, María Guerrero-Marin, et al.Therapeutic Advances in Chronic Disease|November 3, 2021
Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country resultsErika Ruiz-Garcia, Adriana Peña-Nieves, Jorge Alegria-Baños, et al.Practical Radiation Oncology|October 24, 2020
Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice GuidelineJennifer Y Wo, Christopher J Anker, Jonathan B Ashman, et al.World Neurosurgery|October 28, 2023
Extent of Surgical Resection as a Predictor of Tumor Progression in Skull Base Chordomas: A Multicenter Volumetric AnalysisCarlos Perez-Vega, Oluwaseun O Akinduro, Henry J Ruiz-Garcia, et al.Journal of Global Oncology|September 23, 2018
Frequency of BRAF V600E Mutation in the Mexican Population of Patients With Metastatic MelanomaErika Ruiz-Garcia, Juan A Matus-Santos, Jorge Alberto Guadarrama-Orozco, et al.Cancer Biology & Therapy|May 5, 2012
Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapyMayra Ramos-Suzarte, Patricia Lorenzo-Luaces, Nery Gonzalez Lazo, et al.Arthritis Care & Research|April 15, 2010
Development and initial validation of a self-assessed lupus organ damage instrumentKaren H Costenbader, Munther Khamashta, Silvia Ruiz-Garcia, et al.Pageof 32